BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

Abstract Background Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life (HRQoL). We tested prospectively the psychometric properties of the Bone Metastasis Quality of Life (BOMET-QoL-10) measure on MBC patients...

Full description

Bibliographic Details
Main Authors: A. Barnadas, M. Muñoz, M. Margelí, J. I. Chacón, J. Cassinello, S. Antolin, E. Adrover, M. Ramos, E. Carrasco, M. A. Jimeno, B. Ojeda, X. González, S. González, M. Constenla, J. Florián, A. Miguel, A. Llombart, A. Lluch, M. Ruiz-Borrego, R. Colomer, S. Del Barco, On behalf of GEICAM, Spanish Breast Cancer Group
Format: Article
Language:English
Published: SpringerOpen 2019-12-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Metastatic breast cancer
Bone metastasis
Quality of life
Psychometric
Treatment
Assessments
Online Access:https://doi.org/10.1186/s41687-019-0161-y

Internet

https://doi.org/10.1186/s41687-019-0161-y

Similar Items